Author of the publication

One-to-many propensity score matching in cohort studies.

, , , , , and . Pharmacoepidemiology and drug safety, (May 2012)Propensity score.
DOI: 10.1002/pds.3263

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy., , , , , , and . Pharmacoepidemiology and drug safety, 22 (8): 810-8 (August 2013)Propensity score; Oncologia.One-to-many propensity score matching in cohort studies., , , , , and . Pharmacoepidemiology and drug safety, (May 2012)Propensity score.Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , and 17 other author(s). 329 (16): 1376 (2023)Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information., , , , and . Medical care, 45 (10 Supl 2): S158-65 (October 2007)6354<m:linebreak></m:linebreak>LR: 20091118; GR: R01 023178/PHS HHS/United States; GR: R01 AG023178-03/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Anti-Inflammatory Agents, Non-Steroidal); RF: 46; NIHMS40822; OID: NLM: NIHMS40822; OID: NLM: PMC2265540; ppublish;<m:linebreak></m:linebreak>CER.Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect., , , , , , and . American journal of epidemiology, 163 (3): 262-70 (February 2006)The Wilcoxon signed rank test for paired comparisons of clustered data., , and . Biometrics, 62 (1): 185-92 (March 2006)4150<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print; GR: EY 12269/EY/NEI; JID: 0370625; 1406-18-4 (Vitamin E); ppublish;<m:linebreak></m:linebreak>Dissenys de cluster.Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, , , , , , , , , and 18 other author(s). N Engl J Med, 377 (12): 1119--1131 (Aug 27, 2017)Role of disease risk scores in comparative effectiveness research with emerging therapies., , and . Pharmacoepidemiology and drug safety, (May 2012)Propensity score; Disease risk score; CER.Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study., , , and . American journal of epidemiology, 172 (7): 843-54 (October 2010)5732<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;<m:linebreak></m:linebreak>Propensity score.A randomized study of how physicians interpret research funding disclosures., , , , , , , , and . The New England journal of medicine, 367 (12): 1119-27 (September 2012)6941<m:linebreak></m:linebreak>GR: 2R25CA092203-08/CA/NCI NIH HHS/United States; GR: K08HS18465-01/HS/AHRQ HHS/United States; JID: 0255562; CIN: N Engl J Med. 2012 Sep 20;367(12):1152-3. PMID: 22992081; ppublish;<m:linebreak></m:linebreak>Publicació; Interpretació de resultats; Indústria; RCT.